2,338,468 Shares CHEMBIO DIAGNOSTICS, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • May 11th, 2020 • Chembio Diagnostics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2020 Company Industry JurisdictionChembio Diagnostics, Inc., a Nevada corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom Robert W. Baird & Co. Incorporated is acting as representative (the “Representative”), subject to the terms and conditions set forth herein, an aggregate of 2,338,468 shares (the “Firm Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”).